Christopher Downs insider trades

Open-market stock purchases and sales by Christopher Downs, Chief Financial Officer at CNS Pharmaceuticals, Inc, from SEC Form 4 filings since Aug 18, 2016.

Recent trades

DateStockTradeValue
Nov 17, 2025CNSP CNS Pharmaceuticals, IncBought (not open market)—

Companies traded

  • CNSP CNS Pharmaceuticals, Inc: 6 buys, last Nov 17, 2025
  • EBET EBET, Inc: other filings, last Feb 9, 2023
  • INFU InfuSystem Holdings, Inc: 1 buy, last Sep 7, 2017

Get free alerts when Christopher Downs files a new trade →